Description: Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
Home Page: www.daxor.com
DXR Technical Analysis
109 Meco Lane
Oak Ridge,
TN
37830
United States
Phone:
212 330 8500
Officers
| Name | Title |
|---|---|
| Mr. Michael Richard Feldschuh | Chairman, Pres & CEO |
| Mr. Jonathan Adam Feldschuh | Chief Scientific Officer & Director |
| Mr. Robert J. Michel CPA, CPA, M.B.A. | CFO, Chief Compliance Officer & Corp. Sec. |
| Ms. Kathryn A. Kornafel | VP of Marketing & Commercial Devel. |
| Mr. Guido Manzo | VP of Sales |
| Ms. Jean Oertel | Sr. VP Commercialization & Customer Experience |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 8.9095 |
| Price-to-Book MRQ: | 2.0645 |
| Price-to-Sales TTM: | 144.6185 |
| IPO Date: | 1992-03-17 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |